Clinical Trial Update: Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 single ascending dose study of Bristol-Myers Squibb's BMS-820132 in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BMS-820132

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Diabetes Mellitus, Non-Insulin-Dependent | Phase 1 | Status: COMPLETED